These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 15060445)

  • 1. Treatment with type-2 selective and non-selective cyclooxygenase inhibitors improves T-cell proliferation in HIV-infected patients on highly active antiretroviral therapy.
    Johansson CC; Bryn T; Aandahl EM; Areklett MA; Aukrust P; Taskén K; Frøland SS
    AIDS; 2004 Apr; 18(6):951-2. PubMed ID: 15060445
    [No Abstract]   [Full Text] [Related]  

  • 2. Seasonal episodic paroxysmal hemicrania responding to cyclooxygenase-2 inhibitors.
    Siow HC
    Cephalalgia; 2004 May; 24(5):414-5. PubMed ID: 15096232
    [No Abstract]   [Full Text] [Related]  

  • 3. Rofecoxib for the treatment of chronic paroxysmal hemicrania.
    Lisotto C; Maggioni F; Mainardi F; Zanchin G
    Cephalalgia; 2003 May; 23(4):318-20. PubMed ID: 12716352
    [No Abstract]   [Full Text] [Related]  

  • 4. Immune modulatory effects of cyclooxygenase type 2 inhibitors in HIV patients on combination antiretroviral treatment.
    Kvale D; Ormaasen V; Kran AM; Johansson CC; Aukrust P; Aandahl EM; Frøland SS; Taskén K
    AIDS; 2006 Apr; 20(6):813-20. PubMed ID: 16549964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune activation and HIV-specific T cell responses are modulated by a cyclooxygenase-2 inhibitor in untreated HIV-infected individuals: An exploratory clinical trial.
    Prebensen C; Trøseid M; Ueland T; Dahm A; Sandset PM; Aaberge I; Waalen K; Dyrhol-Riise AM; Taskén K; Kvale D
    PLoS One; 2017; 12(5):e0176527. PubMed ID: 28464042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term immunological response in HIV-1-infected subjects receiving potent antiretroviral therapy.
    Kaufmann GR; Bloch M; Zaunders JJ; Smith D; Cooper DA
    AIDS; 2000 May; 14(8):959-69. PubMed ID: 10853977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy.
    d'Ettorre G; Forcina G; Andreotti M; Sarmati L; Palmisano L; Andreoni M; Vella S; Mastroianni CM; Vullo V
    Clin Exp Immunol; 2004 Feb; 135(2):280-5. PubMed ID: 14738457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cyclooxygenase-2 inhibitors and relapse of inflammatory bowel disease.
    Biancone L; Tosti C; De Nigris F; Fantini M; Pallone F
    Gastroenterology; 2003 Aug; 125(2):637-8. PubMed ID: 12891585
    [No Abstract]   [Full Text] [Related]  

  • 9. Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers.
    Brzozowski T; Konturek PC; Konturek SJ; Sliwowski Z; Pajdo R; Drozdowicz D; Ptak A; Hahn EG
    Microsc Res Tech; 2001 Jun; 53(5):343-53. PubMed ID: 11376495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selective cyclooxygenase-2 inhibitor rofecoxib may improve the treatment of chronic idiopathic urticaria.
    Boehncke WH; Ludwig RJ; Zollner TM; Ochsendorf F; Kaufmann R; Gibbs BF
    Br J Dermatol; 2003 Mar; 148(3):604-6. PubMed ID: 12653769
    [No Abstract]   [Full Text] [Related]  

  • 11. Total lymphocyte count as a possible surrogate of CD4 cell count to prioritize eligibility for antiretroviral therapy among HIV-infected individuals in resource-limited settings.
    Bedell R; Heath KV; Hogg RS; Wood E; Press N; Yip B; O'Shaughnessy MV; Montaner JS
    Antivir Ther; 2003 Oct; 8(5):379-84. PubMed ID: 14640384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of combination chemotherapy and highly active antiretroviral therapy on immune parameters in HIV-1 associated lymphoma.
    Powles T; Imami N; Nelson M; Gazzard BG; Bower M
    AIDS; 2002 Mar; 16(4):531-6. PubMed ID: 11872995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunological response to highly active antiretroviral therapy in children with clinically stable HIV-1 infection.
    Rosenblatt HM; Stanley KE; Song LY; Johnson GM; Wiznia AA; Nachman SA; Krogstad PA;
    J Infect Dis; 2005 Aug; 192(3):445-55. PubMed ID: 15995958
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune diseases-related arthritis in HIV-infected patients in the era of highly active antiretroviral therapy.
    Yang JJ; Tsai MS; Sun HY; Hsieh SM; Chen MY; Sheng WH; Chang SC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):130-6. PubMed ID: 24064287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma levels of soluble CD27: a simple marker to monitor immune activation during potent antiretroviral therapy in HIV-1-infected subjects.
    De Milito A; Aleman S; Marenzi R; Sonnerborg A; Fuchs D; Zazzi M; Chiodi F
    Clin Exp Immunol; 2002 Mar; 127(3):486-94. PubMed ID: 11966765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of antiretroviral regimes in HIV-1 patients in reducing immune activation.
    Jiménez A; Molero L; Jiménez A; Castañón S; Subirá D; De Górgolas M; Fedz-Guerrero M; García R
    Immunology; 2002 May; 106(1):80-6. PubMed ID: 11972635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study.
    Kaufmann GR; Perrin L; Pantaleo G; Opravil M; Furrer H; Telenti A; Hirschel B; Ledergerber B; Vernazza P; Bernasconi E; Rickenbach M; Egger M; Battegay M;
    Arch Intern Med; 2003 Oct; 163(18):2187-95. PubMed ID: 14557216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical pharmacology of selective inhibitors of cyclooxygenase-2].
    Patrignani P
    Acta Otorhinolaryngol Ital; 2003 Aug; 23(4 Suppl 74):13-8, 37-40. PubMed ID: 15058604
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in CD4+ and CD8+ T cell subsets in response to highly active antiretroviral therapy in HIV type 1-infected patients with prior protease inhibitor experience.
    Gray CM; Schapiro JM; Winters MA; Merigan TC
    AIDS Res Hum Retroviruses; 1998 May; 14(7):561-9. PubMed ID: 9591710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.